nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—SLC22A2—Metformin—polycystic ovary syndrome	0.395	0.535	CbGbCtD
Disopyramide—SLC22A1—Metformin—polycystic ovary syndrome	0.343	0.465	CbGbCtD
Disopyramide—Abdominal bloating—Metformin—polycystic ovary syndrome	0.00664	0.115	CcSEcCtD
Disopyramide—KCND2—pituitary gland—polycystic ovary syndrome	0.00289	0.095	CbGeAlD
Disopyramide—KCND2—adipose tissue—polycystic ovary syndrome	0.00287	0.0946	CbGeAlD
Disopyramide—CYP3A4—urine—polycystic ovary syndrome	0.00269	0.0885	CbGeAlD
Disopyramide—KCND3—uterus—polycystic ovary syndrome	0.00256	0.0844	CbGeAlD
Disopyramide—KCND3—adipose tissue—polycystic ovary syndrome	0.00251	0.0825	CbGeAlD
Disopyramide—KCND2—female gonad—polycystic ovary syndrome	0.0024	0.0791	CbGeAlD
Disopyramide—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00235	0.0407	CcSEcCtD
Disopyramide—KCND3—adrenal gland—polycystic ovary syndrome	0.00225	0.074	CbGeAlD
Disopyramide—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.0021	0.0363	CcSEcCtD
Disopyramide—Abdominal distension—Metformin—polycystic ovary syndrome	0.002	0.0345	CcSEcCtD
Disopyramide—Sweating increased—Metformin—polycystic ovary syndrome	0.00193	0.0334	CcSEcCtD
Disopyramide—Neutropenia—Metformin—polycystic ovary syndrome	0.00185	0.0321	CcSEcCtD
Disopyramide—Drowsiness—Metformin—polycystic ovary syndrome	0.00177	0.0306	CcSEcCtD
Disopyramide—Bradycardia—Metformin—polycystic ovary syndrome	0.00162	0.028	CcSEcCtD
Disopyramide—Hepatitis—Metformin—polycystic ovary syndrome	0.00159	0.0275	CcSEcCtD
Disopyramide—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00158	0.0273	CcSEcCtD
Disopyramide—ORM1—endometrium—polycystic ovary syndrome	0.00152	0.0502	CbGeAlD
Disopyramide—Flatulence—Metformin—polycystic ovary syndrome	0.00136	0.0236	CcSEcCtD
Disopyramide—Dysgeusia—Metformin—polycystic ovary syndrome	0.00135	0.0234	CcSEcCtD
Disopyramide—Vision blurred—Metformin—polycystic ovary syndrome	0.0013	0.0225	CcSEcCtD
Disopyramide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00128	0.0222	CcSEcCtD
Disopyramide—SLC22A1—adipose tissue—polycystic ovary syndrome	0.00126	0.0414	CbGeAlD
Disopyramide—SCN5A—vagina—polycystic ovary syndrome	0.00125	0.0412	CbGeAlD
Disopyramide—Malaise—Metformin—polycystic ovary syndrome	0.00125	0.0216	CcSEcCtD
Disopyramide—Syncope—Metformin—polycystic ovary syndrome	0.00124	0.0214	CcSEcCtD
Disopyramide—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00121	0.021	CcSEcCtD
Disopyramide—Chest pain—Metformin—polycystic ovary syndrome	0.00118	0.0203	CcSEcCtD
Disopyramide—Discomfort—Metformin—polycystic ovary syndrome	0.00116	0.0201	CcSEcCtD
Disopyramide—Oedema—Metformin—polycystic ovary syndrome	0.00113	0.0195	CcSEcCtD
Disopyramide—Shock—Metformin—polycystic ovary syndrome	0.00111	0.0192	CcSEcCtD
Disopyramide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.0011	0.0191	CcSEcCtD
Disopyramide—Skin disorder—Metformin—polycystic ovary syndrome	0.0011	0.0189	CcSEcCtD
Disopyramide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00109	0.0189	CcSEcCtD
Disopyramide—Anorexia—Metformin—polycystic ovary syndrome	0.00107	0.0186	CcSEcCtD
Disopyramide—ORM1—endocrine gland—polycystic ovary syndrome	0.00107	0.0352	CbGeAlD
Disopyramide—Hypotension—Metformin—polycystic ovary syndrome	0.00105	0.0182	CcSEcCtD
Disopyramide—SLC22A1—vagina—polycystic ovary syndrome	0.00105	0.0344	CbGeAlD
Disopyramide—CHRM3—adipose tissue—polycystic ovary syndrome	0.00104	0.0343	CbGeAlD
Disopyramide—Paraesthesia—Metformin—polycystic ovary syndrome	0.00101	0.0175	CcSEcCtD
Disopyramide—Dyspnoea—Metformin—polycystic ovary syndrome	0.00101	0.0174	CcSEcCtD
Disopyramide—Somnolence—Metformin—polycystic ovary syndrome	0.001	0.0173	CcSEcCtD
Disopyramide—CHRM2—endocrine gland—polycystic ovary syndrome	0.000996	0.0328	CbGeAlD
Disopyramide—Dyspepsia—Metformin—polycystic ovary syndrome	0.000992	0.0172	CcSEcCtD
Disopyramide—Decreased appetite—Metformin—polycystic ovary syndrome	0.00098	0.017	CcSEcCtD
Disopyramide—SLC22A1—endocrine gland—polycystic ovary syndrome	0.000979	0.0322	CbGeAlD
Disopyramide—Fatigue—Metformin—polycystic ovary syndrome	0.000972	0.0168	CcSEcCtD
Disopyramide—Constipation—Metformin—polycystic ovary syndrome	0.000964	0.0167	CcSEcCtD
Disopyramide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000929	0.0161	CcSEcCtD
Disopyramide—CHRM1—endocrine gland—polycystic ovary syndrome	0.000907	0.0299	CbGeAlD
Disopyramide—Urticaria—Metformin—polycystic ovary syndrome	0.000896	0.0155	CcSEcCtD
Disopyramide—CHRM3—female gonad—polycystic ovary syndrome	0.000873	0.0287	CbGeAlD
Disopyramide—CHRM3—endocrine gland—polycystic ovary syndrome	0.000812	0.0267	CbGeAlD
Disopyramide—Asthenia—Metformin—polycystic ovary syndrome	0.000809	0.014	CcSEcCtD
Disopyramide—Pruritus—Metformin—polycystic ovary syndrome	0.000798	0.0138	CcSEcCtD
Disopyramide—Diarrhoea—Metformin—polycystic ovary syndrome	0.000771	0.0133	CcSEcCtD
Disopyramide—Dizziness—Metformin—polycystic ovary syndrome	0.000746	0.0129	CcSEcCtD
Disopyramide—Vomiting—Metformin—polycystic ovary syndrome	0.000717	0.0124	CcSEcCtD
Disopyramide—Rash—Metformin—polycystic ovary syndrome	0.000711	0.0123	CcSEcCtD
Disopyramide—Dermatitis—Metformin—polycystic ovary syndrome	0.00071	0.0123	CcSEcCtD
Disopyramide—Headache—Metformin—polycystic ovary syndrome	0.000706	0.0122	CcSEcCtD
Disopyramide—Nausea—Metformin—polycystic ovary syndrome	0.00067	0.0116	CcSEcCtD
Disopyramide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000446	0.0147	CbGeAlD
Disopyramide—CHRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.15e-05	0.000353	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—HSD3B2—polycystic ovary syndrome	6.15e-05	0.000352	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.13e-05	0.000352	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	6.08e-05	0.000348	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.07e-05	0.000348	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	6.01e-05	0.000345	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6e-05	0.000344	CbGpPWpGaD
Disopyramide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5.99e-05	0.000344	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	5.98e-05	0.000343	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AKR1C1—polycystic ovary syndrome	5.95e-05	0.000341	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	5.92e-05	0.000339	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SULT2A1—polycystic ovary syndrome	5.88e-05	0.000337	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	5.83e-05	0.000334	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—LHB—polycystic ovary syndrome	5.81e-05	0.000333	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—RRM2—polycystic ovary syndrome	5.69e-05	0.000326	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—HSD3B2—polycystic ovary syndrome	5.68e-05	0.000326	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	5.6e-05	0.000321	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FSHR—polycystic ovary syndrome	5.58e-05	0.00032	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	5.53e-05	0.000317	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AKR1C1—polycystic ovary syndrome	5.5e-05	0.000315	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—YAP1—polycystic ovary syndrome	5.49e-05	0.000315	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	5.48e-05	0.000315	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SULT2A1—polycystic ovary syndrome	5.48e-05	0.000314	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—POMC—polycystic ovary syndrome	5.47e-05	0.000313	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.45e-05	0.000312	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.43e-05	0.000311	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	5.41e-05	0.00031	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	5.39e-05	0.000309	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.38e-05	0.000308	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	5.34e-05	0.000307	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—RRM2—polycystic ovary syndrome	5.3e-05	0.000304	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—NAMPT—polycystic ovary syndrome	5.27e-05	0.000302	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.27e-05	0.000302	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.25e-05	0.000301	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CYP11A1—polycystic ovary syndrome	5.21e-05	0.000299	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.2e-05	0.000298	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.12e-05	0.000294	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—YAP1—polycystic ovary syndrome	5.11e-05	0.000293	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.11e-05	0.000293	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	5.06e-05	0.00029	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.06e-05	0.00029	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	4.99e-05	0.000286	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	4.98e-05	0.000285	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.96e-05	0.000285	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.95e-05	0.000284	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.93e-05	0.000283	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	4.93e-05	0.000283	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AKR1C3—polycystic ovary syndrome	4.92e-05	0.000282	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.91e-05	0.000282	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—NAMPT—polycystic ovary syndrome	4.91e-05	0.000282	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	4.9e-05	0.000281	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.9e-05	0.000281	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	4.89e-05	0.00028	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	4.89e-05	0.00028	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	4.87e-05	0.000279	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.87e-05	0.000279	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	4.86e-05	0.000279	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYP11A1—polycystic ovary syndrome	4.85e-05	0.000278	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CYP17A1—polycystic ovary syndrome	4.84e-05	0.000278	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	4.81e-05	0.000276	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.76e-05	0.000273	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.75e-05	0.000272	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	4.72e-05	0.000271	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.7e-05	0.00027	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.61e-05	0.000265	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.6e-05	0.000264	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.6e-05	0.000264	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.59e-05	0.000263	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	4.58e-05	0.000263	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	4.57e-05	0.000262	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.55e-05	0.000261	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	4.55e-05	0.000261	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	4.54e-05	0.000261	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.54e-05	0.000261	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	4.54e-05	0.00026	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	4.53e-05	0.00026	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	4.51e-05	0.000259	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.51e-05	0.000259	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	4.51e-05	0.000258	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.49e-05	0.000258	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	4.48e-05	0.000257	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	4.46e-05	0.000256	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.45e-05	0.000255	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.36e-05	0.00025	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.34e-05	0.000249	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.3e-05	0.000247	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	4.28e-05	0.000245	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	4.27e-05	0.000245	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	4.24e-05	0.000243	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	4.23e-05	0.000243	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	4.23e-05	0.000243	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	4.23e-05	0.000242	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	4.23e-05	0.000242	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	4.21e-05	0.000242	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	4.19e-05	0.00024	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—TH—polycystic ovary syndrome	4.19e-05	0.00024	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.18e-05	0.00024	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	4.17e-05	0.000239	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.17e-05	0.000239	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	4.16e-05	0.000238	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.13e-05	0.000237	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	4.07e-05	0.000234	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	3.96e-05	0.000227	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	3.95e-05	0.000227	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	3.91e-05	0.000224	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	3.91e-05	0.000224	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—TH—polycystic ovary syndrome	3.9e-05	0.000224	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	3.9e-05	0.000223	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	3.86e-05	0.000222	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	3.86e-05	0.000222	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	3.86e-05	0.000221	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	3.83e-05	0.00022	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	3.8e-05	0.000218	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	3.74e-05	0.000214	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	3.72e-05	0.000214	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	3.69e-05	0.000212	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—TH—polycystic ovary syndrome	3.61e-05	0.000207	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	3.57e-05	0.000205	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.55e-05	0.000204	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.54e-05	0.000203	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	3.51e-05	0.000201	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.5e-05	0.000201	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.5e-05	0.0002	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.48e-05	0.0002	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	3.46e-05	0.000198	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.45e-05	0.000198	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	3.45e-05	0.000198	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	3.42e-05	0.000196	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	3.42e-05	0.000196	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	3.3e-05	0.000189	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	3.26e-05	0.000187	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	3.24e-05	0.000186	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	3.22e-05	0.000184	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	3.22e-05	0.000184	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	3.21e-05	0.000184	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	3.21e-05	0.000184	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	3.19e-05	0.000183	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.18e-05	0.000182	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.18e-05	0.000182	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.1e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.09e-05	0.000177	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	3.09e-05	0.000177	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	3.07e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	3.07e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.06e-05	0.000175	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	3.06e-05	0.000175	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	3.04e-05	0.000174	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.03e-05	0.000174	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.99e-05	0.000172	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.98e-05	0.000171	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.98e-05	0.000171	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.97e-05	0.00017	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.95e-05	0.000169	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	2.94e-05	0.000169	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.94e-05	0.000169	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.93e-05	0.000168	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	2.88e-05	0.000165	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	2.88e-05	0.000165	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.83e-05	0.000162	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	2.82e-05	0.000162	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.81e-05	0.000161	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	2.81e-05	0.000161	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	2.81e-05	0.000161	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	2.8e-05	0.000161	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	2.8e-05	0.00016	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.8e-05	0.00016	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.78e-05	0.000159	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	2.77e-05	0.000159	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.7e-05	0.000155	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.7e-05	0.000155	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	2.68e-05	0.000154	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.67e-05	0.000153	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.66e-05	0.000153	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	2.66e-05	0.000152	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.65e-05	0.000152	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.63e-05	0.000151	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	2.61e-05	0.00015	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	2.49e-05	0.000143	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	2.48e-05	0.000142	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.47e-05	0.000142	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	2.46e-05	0.000141	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.44e-05	0.00014	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.35e-05	0.000135	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.34e-05	0.000134	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	2.33e-05	0.000134	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.32e-05	0.000133	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.31e-05	0.000132	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	2.3e-05	0.000132	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	2.3e-05	0.000132	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—INS—polycystic ovary syndrome	2.29e-05	0.000131	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.28e-05	0.000131	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	2.27e-05	0.00013	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	2.22e-05	0.000127	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	2.18e-05	0.000125	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	2.15e-05	0.000123	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	2.15e-05	0.000123	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—INS—polycystic ovary syndrome	2.13e-05	0.000122	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	2.01e-05	0.000115	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—POMC—polycystic ovary syndrome	1.98e-05	0.000114	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.98e-05	0.000113	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.98e-05	0.000113	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	1.97e-05	0.000113	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—INS—polycystic ovary syndrome	1.97e-05	0.000113	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.95e-05	0.000112	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	1.94e-05	0.000111	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	1.93e-05	0.000111	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.92e-05	0.00011	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	1.91e-05	0.00011	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.85e-05	0.000106	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.77e-05	0.000102	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.75e-05	0.0001	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.73e-05	9.9e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	1.72e-05	9.87e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.7e-05	9.77e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	1.66e-05	9.53e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	1.66e-05	9.5e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.65e-05	9.49e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	1.65e-05	9.48e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	1.65e-05	9.45e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	1.64e-05	9.41e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	1.63e-05	9.36e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.63e-05	9.34e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.6e-05	9.17e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.6e-05	9.16e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	1.59e-05	9.14e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	1.59e-05	9.14e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.58e-05	9.05e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.58e-05	9.05e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.52e-05	8.71e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.51e-05	8.68e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.5e-05	8.6e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.41e-05	8.08e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.37e-05	7.86e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.29e-05	7.39e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.22e-05	7.01e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.22e-05	6.99e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.21e-05	6.92e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.15e-05	6.6e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.1e-05	6.29e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.04e-05	5.99e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.04e-05	5.97e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.04e-05	5.96e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.03e-05	5.91e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	9.69e-06	5.56e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	7.85e-06	4.51e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	7.75e-06	4.44e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	7.7e-06	4.42e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	7.22e-06	4.14e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	7.2e-06	4.13e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	7.13e-06	4.09e-05	CbGpPWpGaD
